The Technical Analyst
Mycotopia Therapies, Inc. [TPIA]
Exchange: OTC Sector: Healthcare Industry: Medical Care Facilities
Mycotopia Therapies, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-23.33% $0.0460
America/New_York / 3 mai 2024 @ 15:43
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.685 mill |
| EPS: | -0.0800 |
| P/E: | -0.570 |
| Earnings Date: | Dec 30, 2022 |
| SharesOutstanding: | 14.90 mill |
| Avg Daily Volume: | 0.0408 mill |
| RATING 2024-05-03 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.570 | sector: PE 29.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.02x |
| Company: PE -0.570 | industry: PE 26.55 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0140 - 0.0780 ( +/- 69.57%) |
| ATR Model: 14 days |
Forecast:
16:00 - $0.0460
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0460 (-23.33% ) |
| Volume | 0.0029 mill |
| Avg. Vol. | 0.0408 mill |
| % of Avg. Vol | 7.04 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For TPIA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
TPIA
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. The company is based in Aventura, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.
Latest Press Releases
2023-12-04 08:30:00 - Press Release
Mycotopia Therapies Acquires Ai Robotics Assets With A Total Transaction Value Of $9 Million
Miami, dec. 04, 2023 (globe newswire) -- mycotopia therapies inc. (“mycotopia therapies”) (“the company”) (otc: tpia) announced today it has purchased certain assets of philon labs, llc ("philon labs"), including patents related to innovative ai robotics based home health products.
2021-07-14 08:30:00 - Press Release
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions
Psytech inc, including the psychiatric therapeutic saas platform tovana solutions and psychiatric clinical network tovana clinics, to become wholly owned subsidiary of wesana health as part of definitive agreement psytech inc, including the psychiatric therapeutic saas platform tovana solutions and psychiatric clinical network tovana clinics, to become wholly owned subsidiary of wesana health as part of definitive agreement
Latest News
2021-07-14 08:30:00 - GlobeNewsWire
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions
PsyTech Inc, including the psychiatric therapeutic SaaS platform Tovana Solutions and psychiatric clinical network Tovana Clinics, to become wholly owned subsidiary of Wesana Health as part of definitive agreement PsyTech Inc, including the psychiatric therapeutic SaaS platform Tovana Solutions and psychiatric clinical network Tovana Clinics, to become wholly owned subsidiary of Wesana Health as part of definitive agreement